Advances in the study of chronic allograft rejection

Current Opinion in Organ Transplantation

Volumn 8, Issue 2, 2003, Pages 167-171

  Orosz, Charles G ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33846631739     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/00075200-200306000-00007     Document Type: Review

References (49)

1. Halloran PF: Call for revolution: a new approach to describing allograft deterioration. Am J Transplant 2002, 2:195-200
2. Okada M, Wang CY, Hwang DW, et al.: Transcriptional control of cardiac allograft vasculopathy by early growth response gene-1 (Egr-1). Circ Res 2002, 91:135-142.
3. Tsukioka K, Suzuki J, Fujimori M, et al. Expression of matrix metalloproteinases in cardiac allograft vasculopathy and its attenuation by anti MMP-2 ribozyme gene transfection. Cardiovasc Res 2002, 56:472-478.
4. Shintani T, Sawa Y, Takahashi T, et al.: Intraoperative transfection of vein grafts with the NFkappaB decoy in a canine aortocoronary bypass model: a strategy to attenuate intimal hyperplasia. Ann Thorac Surg 2002, 74:1132-1138.
5. Chiffoleau E, Beriou G, Dutartre P, et al.: Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment. J Immunol 2002, 168:5058-5069.
6. Laskowski IA, Pratschke J, Wilhelm MJ, et al.: Anti-CD28 monoclonal antibody therapy prevents chronic rejection of renal allografts in rats. J Am Soc Nephrol 2002, 13:519-527.
7. Song HK, Alters SE, Fathman CG: Evidence that anti-CD8 abrogates anti-CD4-mediated clonal anergy but allows allograft survival in mice. Transplantation1993, 5:133-139.
8. Ji P, Si MS, Podnos Y, et al.: Prevention of chronic rejection by pravastatin in a rat kidney transplant model. Transplantation 2002, 74:821-827.
9. Shirasugi N, Adams AB, Durham MM, et al.: Prevention of chronic rejection in murine cardiac allografts: a comparison of chimerism- and nonchimerisminducing costimulation blockade-based tolerance induction regimens. J Immunol 2002, 169:2677-2684.
10. Hardinger KL, Wang CD, Schnitzler MA, et al.: Prospective, pilot, open-label, short-term study of conversion to leflunomide reverses chronic renal allograft dysfunction. Am J Transplant 2002, 2:867-871.
11. Song E, Zou H, Yao Y, et al.: Early application of Met-RANTES ameliorates chronic allograft nephropathy. Kidney Int 2002, 61:676-685.
12. Shimizu A, Yamada K, Sachs DH, et al.: Persistent rejection of peritubular capillaries and tubules is associated with progressive interstitial fibrosis. Kidney Int 2002, 61:1867-1879.
13. Hillebrands JL, Klatter FA, van den Hurk BM, et al.: Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest 2001, 107:1411-1422.
14. Subramanian SV, Kelm RJ, Polikandriotis JA, et al.: Reprogramming of vascular smooth muscle α-actin gene expression as an early indicator of dysfunctional remodeling following heart transplant. Cardiovasc Res 2002, 54:539-548.
15. Yun JJ, Fischbein MP, Whiting D, et al.: The role of MIG/CXCL9 in cardiac allograft vasculopathy. Am J Pathol 2002, 161:1307-1313.
16. Paranya G, Vineberg S, Dvorin E, et al.: Aortic valve endothelial cells undergo transforming growth factor-beta-mediated and non-transforming growth factor-beta-mediated transdifferentiation in vitro. Am J Pathol 2001, 159:1335-1343.
17. Cantin B, Wen P, Zhu D, et al.: Transplant coronary artery disease: a novel model independent of cellular alloimmune response. Circulation 2001, 104:2615-2619.
18. Russell PS, Chase CM, Sykes M, et al.: Tolerance, mixed chimerism, and chronic transplant arteriopathy. J Immunol 2001, 167:5731-5740.
19. Valujskikh A, Matesic D, Gilliam A, et al.: T cells reactive to a single immunodominant self-restricted allopeptide induce skin graft rejection in mice. J Clin Invest 1998, 101:1398-1407.
20. Ensminger SM, Spriewald BM, Witzke O, et al.: Indirect allorecognition can play an important role in the development of transplant arteriosclerosis. Transplantation 2002, 73:279-286.
21. Smith MA, Jaramillo A, SivaSai KS, et al.: Indirect recognition and antibody production against a single mismatched HLA-A2-transgenic molecule precede the development of obliterative airway disease in murine heterotopic tracheal allografts. Transplantation 2002, 73:186-193.
22. Szeto WY, Krasinskas AM, Kreisel D, et al.: Depletion of recipient CD4+ but not CD8+ T lymphocytes prevents the development of cardiac allograft vasculopathy. Transplantation 2002, 73:1116-1122.
23. Fischbein MP, Yun J, Laks H, et al.: Role of CD8+ lymphocytes in chronic rejection of transplanted hearts. J Thorac Cardiovasc Surg 2002, 123:803-809.
24. Ardehali A, Fischbein MP, Yun J, et al.: Indirect alloreactivity and chronic rejection. Transplantation 2002, 73:1805-1807.
25. Baker RJ, Hernandez-Fuentes MP, Brookes PA, et al.: Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: implications for the pathogenesis of chronic allograft nephropathy. J Immunol 2001, 167:7199-7206.
26. Najafian N, Salama AD, Fedoseyeva EV, et al.: Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLADR peptides: potential novel assay for prediction of outcomes for renal transplant recipients. J Am Soc Nephrol 2002, 13:252-259.
27. Xu W, Baelde HJ, Lagaaij EL, et al.: Endothelial cell chimerism after renal transplantation in a rat model. Transplantation 2002, 74:1316-1320.
28. Johnson P, Carpenter M, Hirsch G, et al.: Recipient cells form the intimal proliferative lesion in the rat aortic model of allograft arteriosclerosis. Am J Transplant 2002, 2:207-214.
29. Religa P, Bojakowski K, Maksymowicz M, et al.: Smooth-muscle progenitor cells of bone marrow origin contribute to the development of neointimal thickenings in rat aortic allografts and injured rat carotid arteries. Transplantation 2002, 74:1310-1315.
30. Glaser R, Lu MM, Narula N, et al.: Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation 2002, 106:17-19.
31. Zeisberg M, Bonner G, Maeshima Y, et al.: Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. Am J Pathol 2001, 159:1313-1321.
32. Fan JM, Ng YY, Hill PA, et al.: Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 1999, 56:1455-1467.
33. Gore-Hyer E, Shegogue D, Markiewicz M, et al.: TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells. Am J Physiol Renal Physiol 2002, 283:F707-F716.
34. Guillot C, Guillonneau C, Mathieu P, et al.: Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection. J Immunol 2002, 168:1600-1609.
35. Maluf DG, Fisher RA, Riley R, et al.: Immunobiology and long-term graft function in a transplant heterotopic renal rat model. Clin Transpl 2002, 16(suppl 7):6-14.
36. Johnston DR, Sayegh MH, Madsen JC: Overcoming cardiac allograft vasculopathy (CAV) by inducing tolerance. Front Biosci 2002, 7:e116-e118.
37. Corbascio M, Mahanty H, Osterholm C, et al.: Anti-lymphocyte functionassociated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 liganddeficient mice. Transplantation 2002, 74:35-41.
38. Bickerstaff AA, Wang JJ, Pelletier RP, et al.: Murine renal allografts: spontaneous acceptance is associated with regulated T cell-mediated immunity. J Immunol 2001, 167:4821-4827.
39. Bickerstaff AA, VanBuskirk AM, Wakely E, et al.: Transforming growth factor-β and interleukin-10 subvert alloreactive delayed type hypersensitivity in cardiac allograft acceptor mice. Transplantation 2000, 69:1517-1520
40. Hara M, Kingsley CI, Niimi M, et al.: Il-10 is required for regulatory t cells to mediate tolerance to alloantigens in vivo. J Immunol 2001, 166:3789-3796.
41. Kingsley CI, Karim M, Bushell AR, et al.: CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002, 168:1080-1086.
42. Gagne K, Brouard S, Guillet M, et al.: TGF-β1 and donor dendritic cells are common key components in donor-specific blood transfusion and anti-class II heart graft enhancement, whereas tolerance induction also required inflammatory cytokines down-regulation. Eur J Immunol 2001, 31:3111-3120.
43. Eugui EM: Fibrogenesis in chronic allograft rejection: underlying mechanisms and pharmacological control. Transplant Proc 2002, 34:2867-2871.
44. VanBuskirk AM, Burlingham WJ, Jankowska-Gan E, et al.: Human allograft acceptance is associated with immune regulation. J Clin Invest 2000, 106:145-155.
45. Valujskikh A, Fedoseyeva E, Benichou G, et al.: Development of autoimmunity after skin graft rejection via an indirect alloresponse. Transplantation 2002, 73:1130-1137.
46. Fedoseyeva EV, Kishimoto K, Rolls HK, et al.: Modulation of tissue-specific immune response to cardiac myosin can prolong survival of allogeneic heart transplants. J Immunol 2002, 169:1168-1174.
47. Haque MA, Mizobuchi T, Yasufuku K, et al.: Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J Immunol 2002, 169:1542-1549.
48. Yasufuku K, Heidler KM, Woods KA, et al.: Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance. Transplantation 2002, 73:500-505.
49. Rolls HK, Kishimoto K, Dong VM, et al.: T-cell response to cardiac myosin persists in the absence of an alloimmune response in recipients with chronic cardiac allograft rejection. Transplantation 2002, 74:1053-1057.